Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma

PURPOSE: To detect early response to sunitinib treatment in metastatic clear cell renal cancer (mRCC) using multiparametric MRI. METHOD: Participants with mRCC undergoing pre-surgical sunitinib therapy in the prospective NeoSun clinical trial (EudraCtNo: 2005-004502-82) were imaged before starting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ursprung, Stephan, Priest, Andrew N., Zaccagna, Fulvio, Qian, Wendi, Machin, Andrea, Stewart, Grant D., Warren, Anne Y., Eisen, Timothy, Welsh, Sarah J., Gallagher, Ferdia A., Barrett, Tristan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547646/
https://www.ncbi.nlm.nih.gov/pubmed/34699525
http://dx.doi.org/10.1371/journal.pone.0258988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547646/
https://www.ncbi.nlm.nih.gov/pubmed/34699525
http://dx.doi.org/10.1371/journal.pone.0258988

Ejemplares similares